What is the price of Veradermics, Incorporated (MANE)

The price of Veradermics, Incorporated (MANE) is $102.37

What is the market cap of Veradermics, Incorporated (MANE)

The market cap of Veradermics, Incorporated (MANE) is $4.28B

Veradermics, Incorporated (MANE) Price History

Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. The company's development pipeline includes treatments for Pattern Hair Loss (PHL), impacting both adult and pediatric demographics. A flagship offering is VDPHL01, an orally administered, non-hormonal medication specifically for chronic hair loss management in both male and female patients with PHL. Furthermore, Veradermics is progressing with VDMN, an innovative dissolvable microarray patch technology employing immunotherapy for common warts. Its research also extends to VDAA for addressing alopecia areata, and VDMC, aimed at molluscum contagiosum. Collectively, the firm's product candidates target conditions such as androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. Veradermics caters to healthcare practitioners and clinicians specializing in dermatologic and aesthetic care for patients of all ages, in addition to the wider medical and scientific community engaged in dermatology. Founded in 2019, the company is based in New Haven, Connecticut.

Year	Performance
Not enough data for the provided dates.

Year

Performance

Not enough data for the provided dates.

Company	Stock price	Change 1y%	Country
Vertex Pharmaceuticals Incorporated VRTX.US	$553.09	42.85%	US
Argenx SE ARGX.US	$1.02K	44.02%	NL
Moderna, Inc. MRNA.US	$158.64	541.49%	US
CSL Limited CSL.AX	$121.62	-12.98%	AU
Lonza Group AG LONN.SW	$765.51	6.39%	CH

Company

Stock price

Change 1y%

Country